Tony, H-P, Burmester, G, Schulze-Koops, H, Grunke, M, Henes, J, Kötter, I, Haas, J, Unger, L, Lovric, S, Haubitz, M, Fischer-Betz, R, Chehab, G, Rubbert-Roth, A, Specker, C, Weinerth, J, Holle, J, Müller-Ladner, U, König, R, Fiehn, C, Burgwinkel, P, Budde, K, Sörensen, H, Meurer, M, Aringer, M, Kieseier, B, Erfurt-Berge, C, Sticherling, M, Veelken, R, Ziemann, U, Strutz, F, von Wussow, P, Meier, FMP, Hunzelmann, N, Schmidt, E, Bergner, R, Schwarting, A, Eming, R, Hertl, M, Stadler, R, Schwarz-Eywill, M, Wassenberg, S, Fleck, M, Metzler, C, Zettl, U, Westphal, J, Heitmann, S, Herzog, AL, Wiendl, H, Jakob, W, Schmidt, E, Freivogel, K & Dörner, T 2011, '
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).',
ARTHRITIS RESEARCH AND THERAPY, vol. 13, no. 3, pp. R75.
https://doi.org/10.1186/ar3337